122 related articles for article (PubMed ID: 22687727)
1. [Regulation of human β-1,4-galactosyltransferase V gene expression in cancer cells].
Sato T; Furukawa K
Yakugaku Zasshi; 2012; 132(6):691-7. PubMed ID: 22687727
[TBL] [Abstract][Full Text] [Related]
2. Sequential action of Ets-1 and Sp1 in the activation of the human beta-1,4-galactosyltransferase V gene involved in abnormal glycosylation characteristic of cancer cells.
Sato T; Furukawa K
J Biol Chem; 2007 Sep; 282(38):27702-12. PubMed ID: 17656364
[TBL] [Abstract][Full Text] [Related]
3. Involvement of murine β-1,4-galactosyltransferase V in lactosylceramide biosynthesis.
Kumagai T; Sato T; Natsuka S; Kobayashi Y; Zhou D; Shinkai T; Hayakawa S; Furukawa K
Glycoconj J; 2010 Oct; 27(7-9):685-95. PubMed ID: 21057870
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the human beta-1,4-galactosyltransferase V gene in cancer cells: essential role of transcription factor Sp1.
Sato T; Furukawa K
J Biol Chem; 2004 Sep; 279(38):39574-83. PubMed ID: 15263012
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Transcription Factor Sp1 Suppresses Malignant Properties of A549 Human Lung Cancer Cell Line with Decreased β4-Galactosylation of Highly Branched N-Glycans.
Muramoto K; Tange R; Ishii T; Miyauchi K; Sato T
Biol Pharm Bull; 2017 Aug; 40(8):1282-1288. PubMed ID: 28529241
[TBL] [Abstract][Full Text] [Related]
6. Correlated gene expression between beta-1,4-galactosyltransferase V and N-acetylglucosaminyltransferase V in human cancer cell lines.
Sato T; Shirane K; Kido M; Furukawa K
Biochem Biophys Res Commun; 2000 Oct; 276(3):1019-23. PubMed ID: 11027584
[TBL] [Abstract][Full Text] [Related]
7. Lactosylceramide synthase β-1,4-GalT-V: A novel target for the diagnosis and therapy of human colorectal cancer.
Chatterjee SB; Hou J; Bandaru VVR; Pezhouh MK; Syed Rifat Mannan AA; Sharma R
Biochem Biophys Res Commun; 2019 Jan; 508(2):380-386. PubMed ID: 30502090
[TBL] [Abstract][Full Text] [Related]
8. Involvement of beta-1,4-galactosyltransferase V in malignant transformation-associated changes in glycosylation.
Shirane K; Sato T; Segawa K; Furukawa K
Biochem Biophys Res Commun; 1999 Nov; 265(2):434-8. PubMed ID: 10558885
[TBL] [Abstract][Full Text] [Related]
9. Early lethality of beta-1,4-galactosyltransferase V-mutant mice by growth retardation.
Kumagai T; Tanaka M; Yokoyama M; Sato T; Shinkai T; Furukawa K
Biochem Biophys Res Commun; 2009 Feb; 379(2):456-9. PubMed ID: 19114028
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expression of beta-1,4-galactosyltransferases I, II and V during mouse brain development.
Nakamura N; Yamakawa N; Sato T; Tojo H; Tachi C; Furukawa K
J Neurochem; 2001 Jan; 76(1):29-38. PubMed ID: 11145975
[TBL] [Abstract][Full Text] [Related]
11. Distinct patterns of expression of the beta-1,4-galactosyltransferases during testicular development in the mouse.
Zhu D; Shen A; Sun M; Gu J
Mol Cell Biochem; 2003 May; 247(1-2):147-53. PubMed ID: 12841642
[TBL] [Abstract][Full Text] [Related]
12. Regulation of lactosylceramide synthase (glucosylceramide beta1-->4 galactosyltransferase); implication as a drug target.
Chatterjee S; Kolmakova A; Rajesh M
Curr Drug Targets; 2008 Apr; 9(4):272-81. PubMed ID: 18393821
[TBL] [Abstract][Full Text] [Related]
13. Central Role of β-1,4-GalT-V in Cancer Signaling, Inflammation, and Other Disease-Centric Pathways.
Chatterjee S; Yuan R; Thapa S; Talwar R
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203654
[TBL] [Abstract][Full Text] [Related]
14. The acceptor substrate specificity of human beta4-galactosyltransferase V indicates its potential function in O-glycosylation.
van Die I; van Tetering A; Schiphorst WE; Sato T; Furukawa K; van den Eijnden DH
FEBS Lett; 1999 Apr; 450(1-2):52-6. PubMed ID: 10350056
[TBL] [Abstract][Full Text] [Related]
15. Gene expression levels of β4-galactosyltransferase 5 correlate with the tumorigenic potentials of B16-F10 mouse melanoma cells.
Shirane K; Kuji R; Tareyanagi C; Sato T; Kobayashi Y; Furukawa S; Murata T; Kubota S; Ishikawa Y; Segawa K; Furukawa K
Glycobiology; 2014 Jun; 24(6):532-41. PubMed ID: 24653215
[TBL] [Abstract][Full Text] [Related]
16. Elevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator.
Zhu X; Jiang J; Shen H; Wang H; Zong H; Li Z; Yang Y; Niu Z; Liu W; Chen X; Hu Y; Gu J
J Biol Chem; 2005 Apr; 280(13):12503-16. PubMed ID: 15611127
[TBL] [Abstract][Full Text] [Related]
17. Identification of beta-1,4-galactosyltransferase I as a target gene of HBx-induced cell cycle progression of hepatoma cell.
Wei Y; Liu D; Zhou F; Ge Y; Xu J; Yun X; Gu J; Jiang J
J Hepatol; 2008 Dec; 49(6):1029-37. PubMed ID: 18929424
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of beta-1,4-galactosyltransferase I, II, and V in human astrocytoma.
Xu S; Zhu X; Zhang S; Yin S; Zhou L; Chen C; Gu J
J Cancer Res Clin Oncol; 2001 Aug; 127(8):502-6. PubMed ID: 11501750
[TBL] [Abstract][Full Text] [Related]
19. Knockout of mouse beta 1,4-galactosyltransferase-1 gene results in a dramatic shift of outer chain moieties of N-glycans from type 2 to type 1 chains in hepatic membrane and plasma glycoproteins.
Kotani N; Asano M; Iwakura Y; Takasaki S
Biochem J; 2001 Aug; 357(Pt 3):827-34. PubMed ID: 11463354
[TBL] [Abstract][Full Text] [Related]
20. Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation.
Chatterjee S; Ghosh N
Glycobiology; 1996 Apr; 6(3):303-11. PubMed ID: 8724138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
